
|Articles|February 8, 2004
TIMS effective for more than atopic dermatitis
Tacrolimus and pimecrolimus may spring to mind first when atopic dermatitisis diagnosed, but it turns out that these topical immunomodulators are alsoeffective for a host of previously difficult-to-treat diseases. Granulomafaciale, Hailey Hailey disease, hand and foot eczema, and chronic actinicdermatitis are among the lengthy list of conditions these work well for,according to Mark Lebwohl, M.D., professor and chairman, departmentof dermatology, Mt. Sinai School of Medicine.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Sister Clinicians Highlight Cross-Specialty Collaboration in Dermatology and Podiatry
2
A Dual mRNA Vaccine Against Merkel Cell Carcinoma Shows Synergy with PD-1 Blockade
3
Expert Tips for Treating Vitiligo Shared at Elevate-Derm Conference
4
Treatment Plan Expectations and Previewing the 2026 Pipeline
5



















